Pierre S. Sayad
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Pierre S. Sayad
Fennec Pharmaceuticals Inc. reported in an 8-K filed October 30, 2024 that Pierre S. Sayad was appointed Chief Medical Officer ("CMO"), effective October 28, 2024. Pierre S. Sayad has spoken on 2 earnings calls across 1 company, most recently for Fennec Pharmaceuticals Inc. on August 11, 2026.
“On October 28, 2024, Fennec Pharmaceuticals Inc.'s (the "Company") announced the appointments of Mr. Pierre S. Sayad, PhD, M.S., as Chief Medical Officer ("CMO"), Mr. Terry Evans as Chief Commercial Officer ("CCO"), and Ms. Christiana Cioffi, MBA, as Chief Strategy Officer ("CSO"), all of which became effective on October 28, 2024.”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Current
2024-10-28–present
Company network
Recorded roles and call appearances connecting this person to public companies.
Leadership on record at Fennec Pharmaceuticals Inc.
Other people whose current roles at this company are on record from its filings.
- Adrian Haigh COO
- Jeff Hackman Board Member
- Jeffrey S. Hackman Board Member
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.